Skip to content

Clinical trials

Dwarfism, Pituitary trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dwarfism, Pituitary Phase: Not applicable Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20022
20031
20043
20051
20061
20072
20081
20091
20111
20142
20151
20171
20182
20191
20201
20242
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Unknown status6
Terminated2
Recruiting2
Not yet recruiting2
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Aarhus4
Cliniques universitaires Saint-Luc- Université Catholique de Louvain3
Massachusetts General Hospital2
Rabin Medical Center2
Azienda Ospedaliero-Universitaria di Modena1
Baylor College of Medicine1
Children's Mercy Hospital Kansas City1
Connecticut Children's Medical Center1
Federico II University1
Helsinki University Central Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dwarfism, Pituitary29
Insulin Resistance3
Acromegaly2
Bone Diseases, Metabolic2
Obesity2
Osteoporosis2
Pituitary Diseases2
Pseudohypoparathyroidism2
Addison Disease1
Adrenal Hyperplasia, Congenital1

Trials

Showing 51 to 29 of 29. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.